| Literature DB >> 35428678 |
Grace M Power1,2,3, Aisling M Vaughan1, Luxi Qiao1,4, Nuria Sanchez Clemente1, Julia M Pescarini1, Enny S Paixão1, Ludmila Lobkowicz1, Amber I Raja1, André Portela Souza5, Mauricio Lima Barreto6, Elizabeth B Brickley7.
Abstract
INTRODUCTION: Arthropod-borne viruses (arboviruses) are of notable public health importance worldwide, owing to their potential to cause explosive outbreaks and induce debilitating and potentially life-threatening disease manifestations. This systematic review and meta-analysis aims to assess the relationship between markers of socioeconomic position (SEP) and infection due to arboviruses with mosquito vectors.Entities:
Keywords: arboviruses; epidemiology; public health; systematic review
Mesh:
Year: 2022 PMID: 35428678 PMCID: PMC9014035 DOI: 10.1136/bmjgh-2021-007735
Source DB: PubMed Journal: BMJ Glob Health ISSN: 2059-7908
Figure 1PRISMA flow chart illustrating selection of studies. PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses; SEP, socioeconomic position.
Characteristics of included studies
| Author (year) | Country/ territory | Study period | Type of study | Population | Type of infection | Diagnostic test | Age range | Total size | Frequency measure | Cumulative incidence | NOS |
| DENV | |||||||||||
| USA | October 2004–November 2004 | Cross-sectional | Probability-based, household selection stratified, multistage, cluster-sampling design | DENV | DENV IgM+; DENV IgG+ | All ages | 600 | P | 2%–7.3%; | 5 | |
| Brazil | 2004–2006 | Cross-sectional | Households in Ramal do Granada, were visited between March and April 2004. | DENV | DENV IgG+ | All ages | 405 | P | 18.3% | 6 | |
| Brazil | June 2006–March 2007 | Cross- sectional | All residents aged over 1 year in the three Belo Horizonte districts (Venda Nova, DS Leste and DS Centro-Sul) | DENV | Not specified | All ages | 709 | P | 11.9% (95% CI 9.7% to 14.6%) | 5 | |
| Brazil | 2009–2010 | Cross-sectional | Individuals seeking medical care for acute febrile illness at the only public emergency health unit | DENV | DENV IgM+ and/or RT-PCR+ | >5 years | 2962 | I | 22.0% | 5 | |
| Paraguay | 2014 | Cross-sectional | Inhabitants of three villages | DENV | DENV IgG+ | All ages | 418 | P | 24.2% (95% CI 20.2% to 28.6%) | 5 | |
| Sudan | 2011 | Cross-sectional | Randomly selected community population through multi-stage cluster sampling | DENV | DENV IgG+ | All ages | 540 | P | 9.4% | 6 | |
| Burkina Faso | May 2004–September 2004 | Cross-sectional | Children from Ouagadougou districts with different types and degrees of urbanisation | DENV | DENV IgG+ | 0–12 years | 3015 | P | 22.7% | 6 | |
| Ecuador | 2014–2015 | Cross-sectional | Individuals with DENV infections from sentinel clinics - as well as members of the same household and four neighbouring households located within 200 meters | DENV | DENV NS1 RDT+, RT-PCR+ and/or IgM+ | All ages | 219 | P | 36.5% | 5 | |
| Nigeria | May 2016–August 2016 | Cross-sectional | Patients with febrile illnesses seeking medical assistance at hospital | DENV | DENV NS1 RDT+; DENV IgG+ | 1–49 years | 171 | P | 8.8%; | 3 | |
| Pakistan | 2013–2015 | Cross-sectional | DENV patient samples | DENV | DENV RT-PCR+ | All ages | 59 765 | I | 9.2% | 4 | |
| China | 2013–2015 | Cross-sectional | Samples selected from a 200,000-sample database holding serum collected from community residents living in Liwan and Yuexiu districts of Guangzhou | DENV | DENV IgM+; DENV IgG+ | All ages | 2085 | P | 3.98%; | 3 | |
| Jordan | 2015–2016 | Cross-sectional | Healthy relatives of patients at governmental human health centres at 11 governorates | DENV | DENV IgG+ | 0–80 years | 892 | P | 24.6% | 6 | |
| Colombia | 2010–2012 | Longitudinal serosurvey | School children | DENV | DENV IgG+ | 5–19 years | 4385 | I | 53.8% (2010) to 64.6% (2012) | 5 | |
| Sri Lanka | February 2017– April 2017 | Case–control | Random selection of 200 households reporting past dengue incidence and 200 non-dengue reported households | DENV | N/A | All ages | 4000 | N/A | N/A | 4 | |
| Saudi Arabia | 2017 | Cross-sectional | Residents of the four cities of all genders, age groups, and socioeconomic classes | DENV | DENV IgG+ | All ages | 6397 | P | 26.7% | 6 | |
| Brazil | October 2015–March 2016 | Cross-sectional | Residents of Vila Toninho neighbourhood | DENV | DENV IgG+ | >10 y | 1322 | P | 74.6% | 8 | |
| China | 2015 | Cross-sectional | 850 participants from seven selected communities in Guangzhou with no reported dengue cases before 2014 | DENV | DENV IgG+ | 1-84y | 850 | P | 6.6% | 6 | |
| Malaysia | 2007–2010 | Cross-sectional | Orange Asli populations residing in eight different villages in the forest or forest fringe areas of Peninsular Malaysia | DENV | DENV IgG+ | All ages | 491 | P | 17.0% | 6 | |
| Sudan | August 2017–May 2018 | Cross-sectional | Eleven localities of Kassala state | DENV | DENV IgG+ | All ages | 600 | P | 11.4% | 6 | |
| Nigeria | 2019 | Cross-sectional | Visiting outpatients from the four hospitals in Anyigba | DENV | DENV IgG+ | All ages | 200 | P | 20.5% | 3 | |
| India | 2017 | Case–control | Confirmed dengue patients within 1 year in six districts of the state | DENV | DENV IgM+ | All ages | 767 | N/A | N/A | 8 | |
| CHIKV | |||||||||||
| Mayotte | 2005–2006 | Cross-sectional | Household-based; complex multistage cluster sampling of population of Mayotte | CHIKV | CHIKV IgG+ | ≥2 years | 1154 | P | 37.2% | 6 | |
| Thailand | 2008 | Cross-sectional | Residents aged 18 years or more from three villages | CHIKV | CHIKV IgG+ | >18 years | 507 | P | 61.9% | 5 | |
| Nicaragua | March 2015–April 2016 | Cross-sectional; | Children aged 2–14 years enrolled in the Paediatric Dengue | CHIKV | CHIKV total antibody+ | 2–14 years; >15 years | 3362; | P | 6.1% (2-14 years); | 9; | |
| Colombia | 2014 | Cross-sectional nested in community cohort | 548 suspected CHIKV patients from the COPCORD cohort | CHIKV | CHIKV IgG+ | >18 years | 548 | P | 53.8% | 4 | |
| Brazil | 2016–2017 | Cross-sectional | All households of 3 contiguous valleys in Pau da Lima who are ≥5 years of age | CHIKV | CHIKV IgM+, CHIKV IgG+ | All ages | 1772 | P | 11.8% | 4 | |
| Nigeria | 2018 | Cross-sectional | Febrile participants at five hospitals in Anyigba who test negative for typhoid and malaria | CHIKV | CHIKV IgM+, CHIKV IgG+ | All ages | 243 | P | 34.2% | 3 | |
| JEV | |||||||||||
| China | June 1991–September 1991 | Case–control | Active case finding in hospitals in Gusi County, Henan, China | JEV | JEV IgG+ | >6 months - 10 years | 150 | N/A | N/A | 8 | |
| SINV | |||||||||||
| Sweden | 2009 | Cross-sectional | Randomly selected from population registers | SINV | SINV IgG+ | 25–75 years | 1729 | P | 2.9% | 6 | |
| WNV | |||||||||||
| Jordan | November 2015–May 2016 | Cross-sectional | Healthy relatives of patients seeking healthcare at health centres throughout Jordan. | WNV | WNV IgG+ | 15–50 years | 801 | P | 8.6% | 6 | |
| ZIKV | |||||||||||
| Nicaragua | August 2016–October 2016 | Cohort | Laboratory-confirmed Zika index cases and their household members | ZIKV | ZIKV RT-PCR+ | All ages | 142 | I | 31.0% | 8 | |
| Multiple arboviruses | |||||||||||
| Viet Nam | April 1996–August 1997 | Cross-sectional | Community and hospital-based subjects | DENV; JEV | DENV or JEV IgG+ | All ages | 308 | P | 66.0% | 5 | |
| Laos | January 2009–March 2009 | Cross-sectional | Random selection of 14 households per village and all household members over 6 years age asked to participate | JEV; DENV | NC; JEV HI+; DENV1 HI+; DENV2 HI+; DENV3 HI+; DENV4 HI+ | ≥6 years | 1136 | P | 67.3% (Any flavivirus); | 4 | |
| Kenya | 2007 | Cross-sectional | HIV-negative blood specimens from the 2007 Kenya AIDS Indicator Survey | CHIKV; DENV; RVFV | CHIKV IgG+; DENV IgG+; RVFV IgG+ | 15–64 years | 1091 | P | 0.97%; | 3 | |
| French Guiana | March 2013–June 2014 | Case–controlE | Group of patients infected with CHIKV in 2014 with a group infected with DENV | CHIKV; DENV | CHIKV RT-PCR+; DENV IgM+ | >15 years and 3 months | 336 | N/A | N/A | 6 | |
| Kenya | December 2014–December 2015 | Cohort | Acutely ill children presenting at one of four healthcare centres | Flavivirus, CHIKV; DENV | CHIKV IgG+; DENV IgG+ | All ages | 1604 | P | 3.7% | 6 | |
*The authors report it was not possible to distinguish between DENV and JEV IgG due to cross-reactivity.
CHIKV, Chikungunya virus; DENV, Dengue virus; HI, Hemagglutination inhibition; I, Incidence; Ig, Immunoglobulin; JEV, Japanese Encephalitis virus; N/A, not applicable; NC, not clear; NOS, Newcastle-Ottawa scale; NS1, Non-structural protein 1; P, Prevalence; RDT, Rapid diagnostic test; SINV, Sindbis virus; WNV, West Nile virus; ZIKV, Zika virus.
Figure 2Geographic distribution of studies included in the systematic review. (A) All countries reporting SEP and arboviral infections, (B) Countries reporting SEP and Dengue virus (DENV) infections, (C) Countries reporting SEP and Chikungunya virus infections, (D) Countries reporting on SEP and Japanese encephalitis virus (JEV), Rift Valley fever virus (RVFV), Sindbis virus (SINV), West Nile virus (WNV), Zika virus (ZIKV) or multiple arboviral infections. SEP, socioeconomic position.
Figure 3Meta-analysis for the association between socioeconomic risk markers and arboviral infections. Pooled estimates using random-effects meta-analyses are calculated by subgroups of socioeconomic markers, sex (A), education (B), employment (C), water supply (D) and marital status (E). Subgroups of arboviruses are additionally presented per risk marker. Error bars show the point RR with their 95% CIs on the log scale for each study. Diamonds show the combined point estimate. I2 statistics and Q-test p values are reported. *Indicates cohort study, whereas all others are cross-sectional studies.